Lupus kidney disease under the microscope: new study maps patient health in the gulf

NCT ID NCT04971590

Completed Knowledge-focused Sponsor: GlaxoSmithKline Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 193 people with lupus nephritis (kidney inflammation caused by lupus) in five Gulf countries. Researchers collected information on their symptoms, treatments, and quality of life, but did not test any new medicine. The goal was to better understand the disease and how it affects patients in this region.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lupus nephritis systemic lupus erythematosus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SYSTEMIC LUPUS ERYTHEMATOSUS

Contacts and locations

Show contact details

Locations

GSK Investigational Site

Shweikh, Kuwait
GSK Investigational Site

Bawshar, Oman
GSK Investigational Site

Alrayyan, Qatar
GSK Investigational Site

Abu Dhabi, United Arab Emirates
GSK Investigational Site

Al Ain City, United Arab Emirates
GSK Investigational Site

Dubai, United Arab Emirates